Skip to main content
Vireo Growth Inc. logo

Vireo Growth Inc. — Investor Relations & Filings

Ticker · VREO ISIN · CA38238W1032 CSE Manufacturing
Open in API
Filings indexed 543 across all filing types
Latest filing 2026-04-01 M&A Activity
Country CA Canada
Listing CSE VREO

About Vireo Growth Inc.

https://vireogrowth.com/

Vireo Growth Inc. is a science-focused cannabis company that cultivates, processes, and distributes medical and adult-use cannabis products. The company emphasizes environmentally friendly cultivation practices, often utilizing greenhouses, and manufactures pharmaceutical-grade cannabis extracts. Vireo Growth operates wholesale and retail business lines, selling its portfolio of branded products through company-owned dispensaries and distribution networks. The company's mission is to provide safe access, quality products, and value to its customers, coupled with a commitment to community support and restorative justice programs.

Recent filings

Filing Released Lang Actions
News release - English.pdf
M&A Activity Classification · 90% confidence The document is a corporate press release announcing the closing of Vireo Growth Inc.’s acquisition of Eaze Inc., describing the transaction details, expanded footprint, and management changes. This clearly falls under M&A Activity announcements (mergers and acquisitions).
2026-04-01 English
News release - English.pdf
M&A Activity Classification · 92% confidence The document is a press release announcing the closing of Vireo Growth Inc.’s acquisition of Eaze Inc., detailing transaction terms, expanded footprint, new markets, and management appointments as part of the merger. This clearly falls under announcements related to merger and takeover activity rather than a financial report or earnings release.
2026-04-01 English
Other.pdf
M&A Activity Classification · 90% confidence The document is a Form 8-K “Current Report” filed with the U.S. SEC under Item 8.01 “Entry into a Material Definitive Agreement” describing an Asset Purchase Agreement and related Management Services Agreement with PharmaCann, including the issuance of shares into escrow as transaction consideration. This is clearly an announcement of an M&A transaction rather than a routine earnings release, management change, dividend notice, or other category. Therefore it falls under M&A Activity (Code: TAR).
2026-03-30 English
News release - English.pdf
M&A Activity Classification · 82% confidence The document is a corporate press release announcing the effectiveness of a Management Services Agreement tied to an Asset Purchase Agreement for acquiring PharmaCann’s retail assets. It is not an earnings release, board change, dividend notice, or simple report publication. It directly relates to an acquisition transaction (asset purchase), which falls squarely under M&A Activity.
2026-03-30 English
News release - English.pdf
M&A Activity Classification · 88% confidence The document is a corporate press release providing an update on a non-binding Memorandum of Understanding to acquire a subsidiary (The Hawthorne Gardening Company) from ScottsMiracle-Gro. It details transaction terms (cash, working capital, issuance of shares and warrants), expected closing timeline, and conditions precedent (definitive agreements, regulatory approvals). The primary focus is an announced M&A transaction rather than an earnings release, board/management change, or regulatory notice. Therefore, it fits the M&A Activity category (Code: TAR).
2026-03-30 English
Material change report - English.pdf
Regulatory Filings
2026-03-25 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.